CHDRF yields 2.98% · JNJ yields 2.14%● Live data
📍 CHDRF pulled ahead of the other in Year 1
Combined, CHDRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHDRF + JNJ for your $10,000?
Christian Dior SE, through its subsidiaries, engages in the production, distribution, and retail of fashion and leather goods, wines and spirits, perfumes and cosmetics, and watches and jewelry worldwide. The company offers its fashion and leather goods under the Louis Vuitton, Christian Dior Couture, Loewe, Marc Jacobs, Celine, Kenzo, Givenchy, Pink Shirtmaker, Emilio Pucci, Berluti, Loro Piana, Rimowa brand names; wines and spirits under the Hennessy, Glenmorangie, Ardbeg, a Belvedere, Volcán de mi Tierra, Moët & Chandon, Dom Pérignon, Veuve Clicquot, Krug, Château d'Yquem, Ruinart, Belvedere, Glenmorangie, Newton Vineyards, Bodega Numanthia, and Château d'Esclans brand names; and perfumes and cosmetics under the Parfums Christian Dior, Guerlain, Parfums Givenchy, Make Up For Ever, Benefit Cosmetics, Fresh, Acqua di Parma, KVD Vegan Beauty, Fenty, Ole Henriksen, and Maison Francis Kurkdjian brand names. It also provides watches and jewelry under the Tiffany, Bvlgari, TAG Heuer, Zenith, Hublot, Chaumet, and Fred brand names. In addition, the company operates retail stores under the DFS Galleria, Sephora, Le Bon Marché, and Ile de Beauté names; publishes Le Parisien- Aujourd'hui en France, a daily newspaper; designs and builds yachts; and operates the Cova pastry shops. Further, it is involved in real estate activities under the La Samaritaine brand name; and hotel business. The company sells its products through store network, including e-commerce websites; and agents and distributors. As of December 31, 2021, it operated 5,556 stores. The company was incorporated in 1946 and is headquartered in Paris, France. Christian Dior SE was formerly a subsidiary of Semyrhamis SA.
Full CHDRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.